{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:10:22Z","timestamp":1790878222796,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117208","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T16:35:07Z","timestamp":1722443707000},"page":"117208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Resveratrol reversed rosiglitazone administration induced bone loss in rats with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"178","author":[{"given":"Bo","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimou","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2024.117208_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3158","article-title":"Standards of medical care for type 2 diabetes in China 2019","volume":"35","author":"Jia","year":"2019","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"10.1016\/j.biopha.2024.117208_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.phrs.2018.01.015","article-title":"Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms","volume":"130","author":"Xu","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117208_bib3","first-page":"15","volume":"46","author":"Lee","year":"2022","journal-title":"Insul. Resist.: Mech. Ther. Strateg., Diabetes Metab. J."},{"issue":"9","key":"10.1016\/j.biopha.2024.117208_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/1573399816666200324152517","article-title":"Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes","volume":"16","author":"Ala","year":"2020","journal-title":"Curr. Diabetes Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.117208_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ecl.2013.09.004","article-title":"Osteoporosis-associated fracture and diabetes","volume":"43","author":"Kurra","year":"2014","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"5","key":"10.1016\/j.biopha.2024.117208_bib6","first-page":"837","article-title":"Bone Microarchitecture and Strength in Long-Standing Type 1","volume":"37","author":"Sewing","year":"2022","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2024.117208_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15605\/jafes.032.02.14","article-title":"Bone Metabolism and Fracture Risk in Diabetes Mellitus","volume":"32","author":"Puspitasari","year":"2017","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"key":"10.1016\/j.biopha.2024.117208_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13098-017-0278-1","article-title":"The impact of type 2 diabetes on bone metabolism","volume":"9","author":"Sanches","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"issue":"2","key":"10.1016\/j.biopha.2024.117208_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/joim.12725","article-title":"Type 2 diabetes mellitus and bone","volume":"283","author":"Compston","year":"2018","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.117208_bib10","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00198-018-4638-y","article-title":"Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus","volume":"29","author":"Kanazawa","year":"2018","journal-title":"Osteoporos. Int.: a J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"issue":"2","key":"10.1016\/j.biopha.2024.117208_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ijos.2015.2","article-title":"Diabetes mellitus related bone metabolism and periodontal disease","volume":"7","author":"Wu","year":"2015","journal-title":"Int. J. Oral. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.117208_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11914-016-0329-9","article-title":"Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts","volume":"14","author":"Kalaitzoglou","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.biopha.2024.117208_bib13","first-page":"6354787","article-title":"Molecular Modulation of Osteoblasts and Osteoclasts in Type 2","volume":"2018","author":"Rathinavelu","year":"2018","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2024.117208_bib14","first-page":"Cd006063","article-title":"Rosiglitazone for type 2 diabetes mellitus","volume":"2007","author":"Richter","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"18","key":"10.1016\/j.biopha.2024.117208_bib15","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.2165\/00003495-200767180-00008","article-title":"Rosiglitazone: a review of its use in type 2 diabetes mellitus","volume":"67","author":"Deeks","year":"2007","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.biopha.2024.117208_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1463-1326.2010.01225.x","article-title":"Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes","volume":"12","author":"Aubert","year":"2010","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.biopha.2024.117208_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.735824","article-title":"Effects of anti-diabetic drugs on fracture risk: a systematic review and network meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117208_bib18","first-page":"2121","article-title":"Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized","volume":"35","author":"Wong","year":"2020","journal-title":"Place. -Control. Trial"},{"issue":"14","key":"10.1016\/j.biopha.2024.117208_bib19","first-page":"6352","article-title":"Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells","volume":"23","author":"Chen","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2024.117208_bib20","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.7150\/thno.23620","article-title":"Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice","volume":"8","author":"Lv","year":"2018","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.biopha.2024.117208_bib21","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ptr.2503","article-title":"Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes","volume":"22","author":"Rayalam","year":"2008","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.biopha.2024.117208_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.biopha.2017.03.056","article-title":"The role of SIRT1 in diabetic cardiomyopathy","volume":"90","author":"Karbasforooshan","year":"2017","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117208_bib23","article-title":"Regulation of SIRT1 and Its Roles in","volume":"13","author":"Yang","year":"2022","journal-title":"Inflamm., Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117208_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111249","article-title":"SIRT1 Regulation in Ageing and Obesity","volume":"188","author":"Pardo","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"6","key":"10.1016\/j.biopha.2024.117208_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCRESAHA.122.320888","article-title":"Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels","volume":"131","author":"Mengozzi","year":"2022","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.117208_bib26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","article-title":"Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation","volume":"43","author":"Singh","year":"2020","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.biopha.2024.117208_bib27","first-page":"333","article-title":"Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications","volume":"10","author":"Yu","year":"2019","journal-title":"attenuates Inflamm. Type 2 Diabet. Rats."},{"issue":"1","key":"10.1016\/j.biopha.2024.117208_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13287-021-02178-z","article-title":"STAT3 activation by catalpol promotes osteogenesis-angiogenesis coupling, thus accelerating osteoporotic bone repair","volume":"12","author":"Chen","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2024.117208_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bone.2018.06.014","article-title":"Bone and plasma citrate is reduced in osteoporosis","volume":"114","author":"Chen","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2024.117208_bib30","doi-asserted-by":"crossref","unstructured":"Z. Lin, H. He, M. Wang, J. Liang, MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate, 52(6) (2019) e12688.","DOI":"10.1111\/cpr.12688"},{"issue":"5","key":"10.1016\/j.biopha.2024.117208_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00774-019-00997-y","article-title":"miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN\/PI3K\/AKT\/FoxO1 pathway","volume":"37","author":"Lou","year":"2019","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.117208_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00223-021-00892-7","article-title":"Resveratrol Promotes Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Through miR-193a\/SIRT7 Axis","volume":"110","author":"Song","year":"2022","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.biopha.2024.117208_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phrs.2005.08.008","article-title":"Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats","volume":"53","author":"El-Batran","year":"2006","journal-title":"Pharmacol. Res."},{"issue":"15","key":"10.1016\/j.biopha.2024.117208_bib34","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.3390\/ijms22158182","article-title":"The Development of Molecular Biology of Osteoporosis","volume":"22","author":"Gao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2024.117208_bib35","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2337\/db10-1672","article-title":"Effect of rosiglitazone on bone quality in a rat model of insulin resistance and osteoporosis","volume":"60","author":"Sardone","year":"2011","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.biopha.2024.117208_bib36","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/jbmr.1918","article-title":"The effect of rosiglitazone on bone mass and fragility is reversible and can be attenuated with alendronate","volume":"28","author":"Kumar","year":"2013","journal-title":"J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.117208_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/ijms20030535","article-title":"The Effects of Resveratrol in the Treatment of Metabolic Syndrome","volume":"20","author":"Hou","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117208_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/iwj.13601","article-title":"The impact of resveratrol on skin wound healing, scarring, and aging","volume":"19","author":"Hecker","year":"2022","journal-title":"Int. Wound J."},{"key":"10.1016\/j.biopha.2024.117208_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","article-title":"Resveratrol for cancer therapy: Challenges and future perspectives","volume":"515","author":"Ren","year":"2021","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2024.117208_bib40","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/ijms20071523","article-title":"Resveratrol and Its Effects on the Vascular System","volume":"20","author":"Breuss","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117208_bib41","doi-asserted-by":"crossref","first-page":"9932218","DOI":"10.1155\/2021\/9932218","article-title":"Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2024.117208_bib42","doi-asserted-by":"crossref","first-page":"8124085","DOI":"10.1155\/2022\/8124085","article-title":"Resveratrol synergistically promotes BMP9-induced osteogenic differentiation of mesenchymal stem cells","volume":"2022","author":"Wang","year":"2022","journal-title":"Stem Cells Int."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:29:46Z","timestamp":1777861786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224010928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":42,"alternative-id":["S0753332224010928"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117208","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol reversed rosiglitazone administration induced bone loss in rats with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117208"}}